Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

SAN JOSE - Anixa Biosciences, Inc. , a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Cleveland Clinic, has received a...

Related Keywords

Japan ,Japanese ,Amit Kumar ,Mike Catelani ,Suparna Mazumder ,Vincent Tuohy ,Justin Johnson ,Anixa Biosciences ,Innovative Breast Cancer Research ,Anixa Biosciences Inc ,Lerner Research Institute ,Japan Patent Office ,Moffitt Cancer Center ,Department Of Inflammation ,National Cancer Institute ,Ovarian Cancer Vaccines ,Iris November Distinguished Chair ,Breast Cancer Research ,Cancer Center ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,News Publishing ,Markets ,